To our knowledge, this is the first time demonstrating such findings in healthy mice, though several models of DIM exposure combined with DSS-induced colitis show that administration of the compound reduces inflammation with accompanying decreases in Il-6 production [38] and ([39] p. 3). Here, IL6 is linked to colitis.